Industry: Chemical & Material
Published Date: 2026-03-12
Pages: 77 Pages
Report ld: 6209736
Request Sample
Customized Report
1,3-Dihydroxyadamantane Market Size(US$)

CAGR 2026-2032
4.4%
Market Size,2032
USD 68.65
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global 1,3-Dihydroxyadamantane market size was US$ 51 million in 2025 and is forecast to reach a readjusted size of US$ 68.65 million by 2032 with a CAGR of 4.4% during the forecast period 2026-2032.
1,3-Dihydroxyadamantane (C10H16O2) is an organic compound that belongs to the class of adamantane derivatives. It has two hydroxyl groups (-OH) attached to the 1st and 3rd positions of the adamantane structure, which is a fused bicyclic compound.
In 2025, the Europe 1,3-Dihydroxyadamantane market was US$ million, while the China market stood at US$ million. Europe accounted for % of the global market in 2025 and China for %. China’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of 1,3-Dihydroxyadamantane include Kerton Chemicals, Matrix Fine Chemicals GmbH, Tianjin Minxiang Biomedical, Sichuan Zhongbang New Material, Hunan Chemfish Pharmaceutical, Shaoxing Catsyn, Yibin chemist Pharmachem, Shanghai Daeyeon Chemical, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in Europe accounted for about % of the market in 2025, while the top three in China held nearly %.
The global 1,3-Dihydroxyadamantane market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of 1,3-Dihydroxyadamantane sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of 1,3-Dihydroxyadamantane manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, 1,3-Dihydroxyadamantane product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the 1,3-Dihydroxyadamantane value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 1,3-Dihydroxyadamantane Product Scope
1.2 1,3-Dihydroxyadamantane by Type
1.2.1 Global 1,3-Dihydroxyadamantane Sales by Type (2021, 2025 & 2032)
1.2.2 Purity99%
1.2.3 Others
1.3 1,3-Dihydroxyadamantane by Application
1.3.1 Global 1,3-Dihydroxyadamantane Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Pharmaceutical Synthesis
1.3.3 Photosensitive Material
1.4 Global 1,3-Dihydroxyadamantane Market Estimates and Forecasts (2021-2032)
1.4.1 Global 1,3-Dihydroxyadamantane Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global 1,3-Dihydroxyadamantane Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global 1,3-Dihydroxyadamantane Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global 1,3-Dihydroxyadamantane Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global 1,3-Dihydroxyadamantane Historical Market Scenario by Region (2021-2026)
2.2.1 Global 1,3-Dihydroxyadamantane Sales Market Share by Region (2021-2026)
2.2.2 Global 1,3-Dihydroxyadamantane Revenue Market Share by Region (2021-2026)
2.3 Global 1,3-Dihydroxyadamantane Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global 1,3-Dihydroxyadamantane Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global 1,3-Dihydroxyadamantane Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 Europe 1,3-Dihydroxyadamantane Market Size and Prospects (2021-2032)
2.4.2 China 1,3-Dihydroxyadamantane Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global 1,3-Dihydroxyadamantane Historical Market Review by Type (2021-2026)
3.1.1 Global 1,3-Dihydroxyadamantane Sales by Type (2021-2026)
3.1.2 Global 1,3-Dihydroxyadamantane Revenue by Type (2021-2026)
3.1.3 Global 1,3-Dihydroxyadamantane Average Price by Type (2021-2026)
3.2 Global 1,3-Dihydroxyadamantane Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global 1,3-Dihydroxyadamantane Sales Forecast by Type (2027-2032)
3.2.2 Global 1,3-Dihydroxyadamantane Revenue Forecast by Type (2027-2032)
3.2.3 Global 1,3-Dihydroxyadamantane Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of 1,3-Dihydroxyadamantane
4 Global Market Size by Application
4.1 Global 1,3-Dihydroxyadamantane Historical Market Review by Application (2021-2026)
4.1.1 Global 1,3-Dihydroxyadamantane Sales by Application (2021-2026)
4.1.2 Global 1,3-Dihydroxyadamantane Revenue by Application (2021-2026)
4.1.3 Global 1,3-Dihydroxyadamantane Average Price by Application (2021-2026)
4.2 Global 1,3-Dihydroxyadamantane Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global 1,3-Dihydroxyadamantane Sales Forecast by Application (2027-2032)
4.2.2 Global 1,3-Dihydroxyadamantane Revenue Forecast by Application (2027-2032)
4.2.3 Global 1,3-Dihydroxyadamantane Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in 1,3-Dihydroxyadamantane Applications
5 Competition Landscape by Players
5.1 Global 1,3-Dihydroxyadamantane Sales by Player (2021-2026)
5.2 Global Top 1,3-Dihydroxyadamantane Players by Revenue (2021-2026)
5.3 Global 1,3-Dihydroxyadamantane Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on 1,3-Dihydroxyadamantane revenue as of 2025
5.4 Global 1,3-Dihydroxyadamantane Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of 1,3-Dihydroxyadamantane, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of 1,3-Dihydroxyadamantane, Product Type & Application
5.7 Global Key Manufacturers of 1,3-Dihydroxyadamantane, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 Europe Market: Players, Segments, Downstream and Major Customers
6.1.1 Europe 1,3-Dihydroxyadamantane Sales by Company
6.1.1.1 Europe 1,3-Dihydroxyadamantane Sales by Company (2021-2026)
6.1.1.2 Europe 1,3-Dihydroxyadamantane Revenue by Company (2021-2026)
6.1.2 Europe 1,3-Dihydroxyadamantane Sales Breakdown by Type (2021-2026)
6.1.3 Europe 1,3-Dihydroxyadamantane Sales Breakdown by Application (2021-2026)
6.1.4 Europe 1,3-Dihydroxyadamantane Major Customers
6.1.5 Europe Market Trends and Opportunities
6.2 China Market: Players, Segments, Downstream and Major Customers
6.2.1 China 1,3-Dihydroxyadamantane Sales by Company
6.2.1.1 China 1,3-Dihydroxyadamantane Sales by Company (2021-2026)
6.2.1.2 China 1,3-Dihydroxyadamantane Revenue by Company (2021-2026)
6.2.2 China 1,3-Dihydroxyadamantane Sales Breakdown by Type (2021-2026)
6.2.3 China 1,3-Dihydroxyadamantane Sales Breakdown by Application (2021-2026)
6.2.4 China 1,3-Dihydroxyadamantane Major Customers
6.2.5 China Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Kerton Chemicals
7.1.1 Kerton Chemicals Company Information
7.1.2 Kerton Chemicals Business Overview
7.1.3 Kerton Chemicals 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Kerton Chemicals 1,3-Dihydroxyadamantane Products Offered
7.1.5 Kerton Chemicals Recent Development
7.2 Matrix Fine Chemicals GmbH
7.2.1 Matrix Fine Chemicals GmbH Company Information
7.2.2 Matrix Fine Chemicals GmbH Business Overview
7.2.3 Matrix Fine Chemicals GmbH 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Matrix Fine Chemicals GmbH 1,3-Dihydroxyadamantane Products Offered
7.2.5 Matrix Fine Chemicals GmbH Recent Development
7.3 Tianjin Minxiang Biomedical
7.3.1 Tianjin Minxiang Biomedical Company Information
7.3.2 Tianjin Minxiang Biomedical Business Overview
7.3.3 Tianjin Minxiang Biomedical 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Tianjin Minxiang Biomedical 1,3-Dihydroxyadamantane Products Offered
7.3.5 Tianjin Minxiang Biomedical Recent Development
7.4 Sichuan Zhongbang New Material
7.4.1 Sichuan Zhongbang New Material Company Information
7.4.2 Sichuan Zhongbang New Material Business Overview
7.4.3 Sichuan Zhongbang New Material 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Sichuan Zhongbang New Material 1,3-Dihydroxyadamantane Products Offered
7.4.5 Sichuan Zhongbang New Material Recent Development
7.5 Hunan Chemfish Pharmaceutical
7.5.1 Hunan Chemfish Pharmaceutical Company Information
7.5.2 Hunan Chemfish Pharmaceutical Business Overview
7.5.3 Hunan Chemfish Pharmaceutical 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Hunan Chemfish Pharmaceutical 1,3-Dihydroxyadamantane Products Offered
7.5.5 Hunan Chemfish Pharmaceutical Recent Development
7.6 Shaoxing Catsyn
7.6.1 Shaoxing Catsyn Company Information
7.6.2 Shaoxing Catsyn Business Overview
7.6.3 Shaoxing Catsyn 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Shaoxing Catsyn 1,3-Dihydroxyadamantane Products Offered
7.6.5 Shaoxing Catsyn Recent Development
7.7 Yibin chemist Pharmachem
7.7.1 Yibin chemist Pharmachem Company Information
7.7.2 Yibin chemist Pharmachem Business Overview
7.7.3 Yibin chemist Pharmachem 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Yibin chemist Pharmachem 1,3-Dihydroxyadamantane Products Offered
7.7.5 Yibin chemist Pharmachem Recent Development
7.8 Shanghai Daeyeon Chemical
7.8.1 Shanghai Daeyeon Chemical Company Information
7.8.2 Shanghai Daeyeon Chemical Business Overview
7.8.3 Shanghai Daeyeon Chemical 1,3-Dihydroxyadamantane Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Shanghai Daeyeon Chemical 1,3-Dihydroxyadamantane Products Offered
7.8.5 Shanghai Daeyeon Chemical Recent Development
8 1,3-Dihydroxyadamantane Manufacturing Cost Analysis
8.1 1,3-Dihydroxyadamantane Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of 1,3-Dihydroxyadamantane
8.4 1,3-Dihydroxyadamantane Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 1,3-Dihydroxyadamantane Distributors List
9.3 1,3-Dihydroxyadamantane Customers
10 1,3-Dihydroxyadamantane Market Dynamics
10.1 1,3-Dihydroxyadamantane Industry Trends
10.2 1,3-Dihydroxyadamantane Market Drivers
10.3 1,3-Dihydroxyadamantane Market Challenges
10.4 1,3-Dihydroxyadamantane Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global 1,3-Dihydroxyadamantane market is projected to grow from US$ 51 million in 2025 to US$ 68.65 million by 2032, at a CAGR of 4.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 140
USD 4900.00
(Single User License)
The global market for 1,3-Dihydroxyadamantane was estimated to be worth US$ 51 million in 2025 and is projected to reach US$ 68.65 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 98
USD 3950.00
(Single User License)
The global 1,3-Dihydroxyadamantane market was valued at US$ 51 million in 2025 and is anticipated to reach US$ 68.65 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 127
USD 2900.00
(Single User License)
The global market for 1,3-Dihydroxyadamantane was valued at US$ 49 million in the year 2024 and is projected to reach a revised size of US$ 66 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published Date: 2025-05-29
Pages: 87
USD 2900.00
(Single User License)
The global market for 1,3-Dihydroxyadamantane was estimated to be worth US$ 49 million in 2024 and is forecast to a readjusted size of US$ 66 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-05-29
Pages: 107
USD 3950.00
(Single User License)
The global 1,3-Dihydroxyadamantane market size was US$ 49 million in 2024 and is forecast to a readjusted size of US$ 66 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published Date: 2025-05-29
Pages: 77
USD 4250.00
(Single User License)
The global 1,3-Dihydroxyadamantane market is projected to grow from US$ 51 million in 2025 to US$ 66 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.
Published Date: 2025-05-29
Pages: 149
USD 4900.00
(Single User License)
The global 1,3-Dihydroxyadamantane market is projected to grow from US$ 51 million in 2025 to US$ 68.65 million by 2032, at a CAGR of 4.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 140
The global market for 1,3-Dihydroxyadamantane was estimated to be worth US$ 51 million in 2025 and is projected to reach US$ 68.65 million, growing at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 98
The global 1,3-Dihydroxyadamantane market was valued at US$ 51 million in 2025 and is anticipated to reach US$ 68.65 million by 2032, at a CAGR of 4.4% from 2026 to 2032.
Published: 2026-03-09
Pages: 127
The global market for 1,3-Dihydroxyadamantane was valued at US$ 49 million in the year 2024 and is projected to reach a revised size of US$ 66 million by 2031, growing at a CAGR of 4.4% during the forecast period.
Published: 2025-05-29
Pages: 87
The global market for 1,3-Dihydroxyadamantane was estimated to be worth US$ 49 million in 2024 and is forecast to a readjusted size of US$ 66 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-05-29
Pages: 107
The global 1,3-Dihydroxyadamantane market size was US$ 49 million in 2024 and is forecast to a readjusted size of US$ 66 million by 2031 with a CAGR of 4.4% during the forecast period 2025-2031.
Published: 2025-05-29
Pages: 77
The global 1,3-Dihydroxyadamantane market is projected to grow from US$ 51 million in 2025 to US$ 66 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.4% during the forecast period.
Published: 2025-05-29
Pages: 149
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now